| |
Dippers (29) |
Non-dippers (57) |
| Anthropometric characteristics |
|
|
| M/F |
25/4 |
52/5 |
| Age, years |
51.25 ± 9.68 |
51.06 ± 10.22
p-0.671 |
| BMI, kg/m2 |
36.59 ± 8.02 |
39.29 ± 6.51
p-0.130 |
| Waist circumference, cm |
121.69 ± 21.17 |
131.69 ± 15.81
p-0.101 |
| Smokers (current/nonsmokers) |
21/8 |
47/10 |
| Sleep study characteristics |
|
|
| Mild to moderate OSA |
12/29(41.4%) |
25/57 (43.8%) |
| Severe OSA |
17/29 (58.6%) |
32/57 (56.2%) |
| AHI, events/h |
46.37± 25.55 |
55.37± 32.10
p-0.303 |
| Glucose metabolism |
|
|
| Current smoking,% |
21/29(72.4%) |
47/57(82.5%) |
| Diabetics |
9/29 (31%) |
13/57(22.8%) |
| Impaired glucose tolerance |
8/29 (27.6%) |
18/57(31.6%) |
| Dyslipidaemia, % |
23/29(79.3) |
39/57(68.4%) |
| Haemodynamic characteristics |
|
|
| Daytime |
|
|
| Average systolic blood pressure, mmHg |
135.6± 13.03 |
129.24± 14.68 |
| Average diastolic blood pressure, mmHg |
82.4± 8.15 |
78.89± 8.73 |
| Nighttime |
|
|
| Average systolic blood pressure, mmHg |
115.95± 8.52 |
127.0± 15.15 |
| Average diastolic blood pressure, mmHg |
67.57± 3.81 |
77.6± 11.06 |
| Concomitant therapy |
|
|
| Antihypertensive treatment |
|
|
| ACE-inhibitors |
15/29(51.7%) |
29/57(50.8%) |
| ARB |
2/29(6.9%) |
6/57(10.5%) |
| B-blockers |
9/29(31%) |
26/57(45.6%) |
| Ca-channel blockers |
10/29(34.5%) |
13/57(22.8%) |
| Diuretics |
16/29(55.2%) |
35/57(61.4%) |
| Proportion of patients receiving all or part of their antihypertensive agents at night, % |
10/32(31%) |
22/57(38%) |
|
